| 查看: 2309 | 回复: 23 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章,编辑回复如下: Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher" agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" ![]() in the following journal: **********************("the Journal" ![]() 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
» 猜你喜欢
2026年机械制造与材料应用国际会议 (ICMMMA 2026)
已经有4人回复
磺酰氟产物,毕不了业了!
已经有6人回复
求助:我三月中下旬出站,青基依托单位怎么办?
已经有9人回复
Cas 72-43-5需要30g,定制合成,能接单的留言
已经有8人回复
北京211副教授,35岁,想重新出发,去国外做博后,怎么样?
已经有8人回复
论文终于录用啦!满足毕业条件了
已经有25人回复
自荐读博
已经有3人回复
不自信的我
已经有5人回复
投稿Elsevier的杂志(返修),总是在选择OA和subscription界面被踢皮球
已经有8人回复
» 本主题相关价值贴推荐,对您同样有帮助:
请大家帮我分析这个产物能不能过柱纯化呢?
已经有27人回复
麻烦大家帮我分析分析
已经有4人回复
各位大牛,帮我分析下出国公派读博,是不是离我越来越远了?
已经有27人回复
大家帮我分析下导师的答复,是不是没有什么希望,谢谢大家了!!!
已经有5人回复
这个导师是什么意思呢,大家帮我分析一下吧。
已经有46人回复
哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
北京和深圳,哪个好呢?请大家帮我分析下
已经有28人回复
大家帮我分析分析
已经有4人回复
【求助】大家来帮我分析下是不是要这么久
已经有14人回复
大家帮我分析一下有没有这种可能呢?谢谢
已经有13人回复
» 抢金币啦!回帖就可以得到:
江汉大学招聘AI for Materials/电解液/锂金属/全固态电池等方面的博士或者博士后
+1/170
原子层沉积(ALD)磁控溅射PECVD等微纳代工服务:18817872921
+1/88
浙江师范大学国家杰青杨启华教授团队招收2026年博士研究生
+1/87
DNA甲基化位点定量试剂盒(qPCR版)-适合特定基因位点5mC定量检测
+1/84
北京—征老婆
+1/82
澳门大学智慧城市物联网国重“结构智能感知、健康监测与无损检测”研究方向博士后招聘
+1/77
华中科技大学郭睿副教授建筑与能源科学课题组诚招博士研究生(2026.1.19截止)
+1/53
中科院理化技术研究所张飞龙研究员/王树涛研究员团队招生(博士/硕士)
+1/36
厦门大学航空航天学院智能制造课题组招2026年申请审核制博士生1-2名
+1/30
南科大薛亚辉课题组诚聘离子输运、低维器件、原子力显微镜等方向“快响行动”博士生
+1/21
征女友 @长安
+1/21
SCI,计算机相关可以写
+1/19
中国科学院大学-杨晗课题组-诚聘-博士后、副研究员
+1/15
【博士后/科研助理招聘-北京理工大学-集成电路与电子学院-国家杰青团队】
+1/9
液晶拓扑光子学博士招生(电子科技大学)
+1/6
浙江大学傅杰团队(杰青)高薪招聘博士后
+1/5
北京工业大学材料学院吴玉锋教授、王长龙研究员招收博士研究生
+1/5
中科院动物所招收2026年博士生(优先少干专项计划、化学或生命科学背景)
+1/3
求博导收留
+1/1
中国科学院苏州纳米所院士团队博士后岗位招聘
+1/1
4楼2011-03-31 16:19:31
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
5楼2011-03-31 16:20:59












agrees to publish
回复此楼
